Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels
Ayumi Kanno, … , Masato Kasuga, Yoshiaki Kido
Ayumi Kanno, … , Masato Kasuga, Yoshiaki Kido
Published May 7, 2020
Citation Information: JCI Insight. 2020;5(9):e128820. https://doi.org/10.1172/jci.insight.128820.
View: Text | PDF
Research Article Endocrinology Metabolism

GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels

  • Text
  • PDF
Abstract

EIF2AK4, which encodes the amino acid deficiency–sensing protein GCN2, has been implicated as a susceptibility gene for type 2 diabetes in the Japanese population. However, the mechanism by which GCN2 affects glucose homeostasis is unclear. Here, we show that insulin secretion is reduced in individuals harboring the risk allele of EIF2AK4 and that maintenance of GCN2-deficient mice on a high-fat diet results in a loss of pancreatic β cell mass. Our data suggest that GCN2 senses amino acid deficiency in β cells and limits signaling by mechanistic target of rapamycin complex 1 to prevent β cell failure during the consumption of a high-fat diet.

Authors

Ayumi Kanno, Shun-ichiro Asahara, Ayuko Furubayashi, Katsuhisa Masuda, Risa Yoshitomi, Emi Suzuki, Tomoko Takai, Maki Kimura-Koyanagi, Tomokazu Matsuda, Alberto Bartolome, Yushi Hirota, Norihide Yokoi, Yuka Inaba, Hiroshi Inoue, Michihiro Matsumoto, Kenichi Inoue, Takaya Abe, Fan-Yan Wei, Kazuhito Tomizawa, Wataru Ogawa, Susumu Seino, Masato Kasuga, Yoshiaki Kido

×

Figure 6

Amino acid levels are reduced and uncharged tRNA levels are increased in the islets of mice fed a HFD.

Options: View larger image (or click on image) Download as PowerPoint
Amino acid levels are reduced and uncharged tRNA levels are increased in...
(A) Concentrations of amino acids in pancreatic islets (NCD, n =8; HFD, n =5) of 24-week-old NCD- or HFD-fed WT mice were determined by metabolome analysis. Relative values are presented according to the indicated color scale for individual animals, with P values less than 0.05 shown in red. (B) Relative amounts of amino acids liberated from tRNA isolated from the pancreatic islets of 24-week-old NCD- or HFD-fed WT mice were determined by metabolome analysis (n =6, 1 sample contains islets from 2 mice). Data in B are the mean ± SEM. *P < 0.05, **P < 0.01 (Student’s t test). Gly, glycine; Ala, alanine; Ser, serine; Pro, proline; Val, valine; Thr, threonine; Ile, isoleucine; Leu, leucine; Asn, asparagine; Asp, aspartic acid; Gln, glutamine; Lys, lysine; Glu, glutamic acid; Met, methionine; His, histidine; Phe, phenylalanine; Arg, arginine; Tyr, tyrosine; Trp, tryptophan.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts